Previous close | 8.26 |
Open | N/A |
Bid | 0.00 |
Ask | 0.00 |
Strike | 740.00 |
Expiry date | 2024-08-16 |
Day's range | 8.26 - 8.26 |
Contract range | N/A |
Volume | |
Open interest | N/A |
Discover how Regeneron sustains robust growth with significant advancements in clinical programs and strategic market maneuvers.
Insightful Analysis of Regeneron's Financials and Strategic Positioning
Regeneron stock jumped early Thursday, bolstered by strong sales of a high-dose version of its blockbuster eye disease treatment, Eylea.